Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae

Shijun Sun,Hua Gao,Yudong Liu,Longyang Jin,Ruobing Wang,Xiaojuan Wang,Qi Wang,Yuyao Yin,Yawei Zhang,Hui Wang
DOI: https://doi.org/10.1080/22221751.2020.1768805
2020-01-01
Abstract:<span>Tigecycline is considered one of the last-resort antimicrobials for carbapenem-resistant <i>K. pneumoniae</i>. Plasmid-mediated tigecycline resistance remains largely unclear. Here, by utilizing whole genome sequencing, we report a plasmid-mediated tigecycline resistance mechanism, a 6,489 bp Resistance-nodulation-division family (RND) efflux pump (<i>tmexCD1-toprJ1 pump</i>), that confers transferable tigecycline resistance in <i>K pneumoniae</i> isolated from patients and chickens. In addition, we identified high prevalence of the plasmids co-harbouring both <i>tmexCD1-toprJ1</i> pump and <i>mcr</i> (<i>tmexCD1-mcr</i> co-harbouring plasmid) from human in our nationwide collection. Even worse, the <i>tmexCD1-toprJ1</i> and <i>mcr</i> co-harbouring plasmid was also co-existed with <i>bla</i> <sub>NDM</sub>-harbouring IncX3 plasmid in the same host, resulting in pandrug resistance. Phylogenetic analysis suggested that the plasmid-borne <i>tmexCD1-toprJ1</i> originated from the chromosome of <i>Aeromonas</i> spp. through Tn<i>5393</i>-mediating translocation. Both plasmid-harbored <i>tmexCD1-toprJ1</i> gene and <i>mcr-8</i> likely originated from animal isolates and then spread to human. Our findings highlight a substantial threat of <i>tmexCD1-toprJ1-mcr8</i> co-harbouring IncFIA/IncFII plasmid to public health due to their mobile resistance to both tigecycline and colistin, emphasizing an urgent need for further global surveillance on this plasmid.</span>
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?